Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling.

Giles DA, Moreno-Fernandez ME, Stankiewicz TE, Graspeuntner S, Cappelletti M, Wu D, Mukherjee R, Chan CC, Lawson MJ, Klarquist J, Sünderhauf A, Softic S, Kahn CR, Stemmer K, Iwakura Y, Aronow BJ, Karns R, Steinbrecher KA, Karp CL, Sheridan R, Shanmukhappa SK, Reynaud D, Haslam DB, Sina C, Rupp J, Hogan SP, Divanovic S.

Nat Med. 2017 Jul;23(7):829-838. doi: 10.1038/nm.4346. Epub 2017 Jun 12. Erratum in: Nat Med. 2017 Oct 6;23 (10 ):1241.

2.

Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.

Porras D, Nistal E, Martínez-Flórez S, Pisonero-Vaquero S, Olcoz JL, Jover R, González-Gallego J, García-Mediavilla MV, Sánchez-Campos S.

Free Radic Biol Med. 2017 Jan;102:188-202. doi: 10.1016/j.freeradbiomed.2016.11.037. Epub 2016 Nov 25.

PMID:
27890642
3.

Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease.

Miura K, Ohnishi H.

World J Gastroenterol. 2014 Jun 21;20(23):7381-91. doi: 10.3748/wjg.v20.i23.7381. Review.

4.

Thermoneutral housing is a critical factor for immune function and diet-induced obesity in C57BL/6 nude mice.

Stemmer K, Kotzbeck P, Zani F, Bauer M, Neff C, Müller TD, Pfluger PT, Seeley RJ, Divanovic S.

Int J Obes (Lond). 2015 May;39(5):791-7. doi: 10.1038/ijo.2014.187. Epub 2014 Oct 28.

5.

Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth SC, Jurczak MJ, Camporez JP, Shulman GI, Gordon JI, Hoffman HM, Flavell RA.

Nature. 2012 Feb 1;482(7384):179-85. doi: 10.1038/nature10809.

6.

Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol.

Rahman K, Desai C, Iyer SS, Thorn NE, Kumar P, Liu Y, Smith T, Neish AS, Li H, Tan S, Wu P, Liu X, Yu Y, Farris AB, Nusrat A, Parkos CA, Anania FA.

Gastroenterology. 2016 Oct;151(4):733-746.e12. doi: 10.1053/j.gastro.2016.06.022. Epub 2016 Jun 21.

7.

Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis.

Pejnovic N, Jeftic I, Jovicic N, Arsenijevic N, Lukic ML.

World J Gastroenterol. 2016 Nov 28;22(44):9706-9717. Review.

8.

NKT cell modulates NAFLD potentiation of metabolic oxidative stress-induced mesangial cell activation and proximal tubular toxicity.

Alhasson F, Dattaroy D, Das S, Chandrashekaran V, Seth RK, Schnellmann RG, Chatterjee S.

Am J Physiol Renal Physiol. 2016 Jan 1;310(1):F85-F101. doi: 10.1152/ajprenal.00243.2015. Epub 2015 Oct 7.

9.

Obesity, fatty liver disease and intestinal microbiota.

Arslan N.

World J Gastroenterol. 2014 Nov 28;20(44):16452-63. doi: 10.3748/wjg.v20.i44.16452. Review.

10.

Regulation of Inflammation by IL-17A and IL-17F Modulates Non-Alcoholic Fatty Liver Disease Pathogenesis.

Giles DA, Moreno-Fernandez ME, Stankiewicz TE, Cappelletti M, Huppert SS, Iwakura Y, Dong C, Shanmukhappa SK, Divanovic S.

PLoS One. 2016 Feb 19;11(2):e0149783. doi: 10.1371/journal.pone.0149783. eCollection 2016.

11.

Novel role of TLR4 in NAFLD development: Modulation of metabolic enzymes expression.

Ferreira DF, Fiamoncini J, Prist IH, Ariga SK, de Souza HP, de Lima TM.

Biochim Biophys Acta. 2015 Oct;1851(10):1353-9. doi: 10.1016/j.bbalip.2015.07.002. Epub 2015 Jul 11.

PMID:
26172853
12.

Deficiency of intestinal mucin-2 protects mice from diet-induced fatty liver disease and obesity.

Hartmann P, Seebauer CT, Mazagova M, Horvath A, Wang L, Llorente C, Varki NM, Brandl K, Ho SB, Schnabl B.

Am J Physiol Gastrointest Liver Physiol. 2016 Mar 1;310(5):G310-22. doi: 10.1152/ajpgi.00094.2015. Epub 2015 Dec 23.

13.

IL-17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice.

Harley IT, Stankiewicz TE, Giles DA, Softic S, Flick LM, Cappelletti M, Sheridan R, Xanthakos SA, Steinbrecher KA, Sartor RB, Kohli R, Karp CL, Divanovic S.

Hepatology. 2014 May;59(5):1830-9. doi: 10.1002/hep.26746. Epub 2014 Mar 27.

14.

Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice.

Ye D, Li FY, Lam KS, Li H, Jia W, Wang Y, Man K, Lo CM, Li X, Xu A.

Gut. 2012 Jul;61(7):1058-67. doi: 10.1136/gutjnl-2011-300269. Epub 2012 Jan 17.

PMID:
22253482
15.

Modulation of the gut microbiota impacts nonalcoholic fatty liver disease: a potential role for bile acids.

Janssen AWF, Houben T, Katiraei S, Dijk W, Boutens L, van der Bolt N, Wang Z, Brown JM, Hazen SL, Mandard S, Shiri-Sverdlov R, Kuipers F, Willems van Dijk K, Vervoort J, Stienstra R, Hooiveld GJEJ, Kersten S.

J Lipid Res. 2017 Jul;58(7):1399-1416. doi: 10.1194/jlr.M075713. Epub 2017 May 22.

16.

Glucoraphanin Ameliorates Obesity and Insulin Resistance Through Adipose Tissue Browning and Reduction of Metabolic Endotoxemia in Mice.

Nagata N, Xu L, Kohno S, Ushida Y, Aoki Y, Umeda R, Fuke N, Zhuge F, Ni Y, Nagashimada M, Takahashi C, Suganuma H, Kaneko S, Ota T.

Diabetes. 2017 May;66(5):1222-1236. doi: 10.2337/db16-0662. Epub 2017 Feb 16.

17.

High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway.

Kim KA, Gu W, Lee IA, Joh EH, Kim DH.

PLoS One. 2012;7(10):e47713. doi: 10.1371/journal.pone.0047713. Epub 2012 Oct 16.

18.

Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD.

Luo Y, Burrington CM, Graff EC, Zhang J, Judd RL, Suksaranjit P, Kaewpoowat Q, Davenport SK, O'Neill AM, Greene MW.

Am J Physiol Endocrinol Metab. 2016 Mar 15;310(6):E418-39. doi: 10.1152/ajpendo.00319.2015. Epub 2015 Dec 15.

19.

Effect of chronic psychosocial stress on nonalcoholic steatohepatitis in mice.

Czech B, Neumann ID, Müller M, Reber SO, Hellerbrand C.

Int J Clin Exp Pathol. 2013 Jul 15;6(8):1585-93. Print 2013.

20.

Altered Gut Microbiota Composition and Immune Response in Experimental Steatohepatitis Mouse Models.

Ishioka M, Miura K, Minami S, Shimura Y, Ohnishi H.

Dig Dis Sci. 2017 Feb;62(2):396-406. doi: 10.1007/s10620-016-4393-x. Epub 2016 Dec 2.

PMID:
27913996

Supplemental Content

Support Center